Tremfya (Janssen Biotech, Inc.)
Welcome to the PulseAid listing for the Tremfya drug offered from Janssen Biotech, Inc.. This Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Janssen Biotech, Inc. |
| NON-PROPRIETARY NAME: | Guselkumab |
| SUBSTANCE NAME: | GUSELKUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-23 Antagonist [EPC],Interleukin-23 Antagonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-07-13 |
| END MARKETING DATE: | 0000-00-00 |
Tremfya HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tremfya from Janssen Biotech, Inc. |
| LABELER NAME: | Janssen Biotech, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/mL) |
| START MARKETING DATE: | 2017-07-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57894-640_e85f926d-ad29-487f-9182-e787c2ffb29b |
| PRODUCT NDC: | 57894-640 |
| APPLICATION NUMBER: | BLA761061 |
Other GUSELKUMAB Pharmaceutical Manufacturers / Labelers:
